YOSHIO YAMAOKA to Case-Control Studies
This is a "connection" page, showing publications YOSHIO YAMAOKA has written about Case-Control Studies.
Connection Strength
0.339
-
Gastric mucosal microbiota in a Mongolian population with gastric cancer and precursor conditions. Aliment Pharmacol Ther. 2020 04; 51(8):770-780.
Score: 0.097
-
New observations regarding Helicobacter pylori and gastric cancer in Mongolia. Helicobacter. 2018 Aug; 23(4):e12491.
Score: 0.086
-
Helicobacter pylori iceA, clinical outcomes, and correlation with cagA: a meta-analysis. PLoS One. 2012; 7(1):e30354.
Score: 0.055
-
Gastric mucosal cytokine levels in relation to host interleukin-1 polymorphisms and Helicobacter pyloricagA genotype. Scand J Gastroenterol. 2005 May; 40(5):530-9.
Score: 0.035
-
Antibody against Helicobacter pylori CagA and VacA and the risk for gastric cancer. J Clin Pathol. 1999 Mar; 52(3):215-8.
Score: 0.023
-
Expression of cytokine mRNA in gastric mucosa with Helicobacter pylori infection. Scand J Gastroenterol. 1995 Dec; 30(12):1153-9.
Score: 0.018
-
Influence of prostate stem cell antigen gene polymorphisms on susceptibility to Helicobacter pylori-associated diseases: a case-control study. Helicobacter. 2015 Apr; 20(2):106-13.
Score: 0.017
-
The interleukin-1 RN polymorphism and Helicobacter pylori infection in the development of duodenal ulcer. Helicobacter. 2004 Dec; 9(6):605-13.
Score: 0.008